BAY3498264
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BAY3498264, covering 2026-04-20 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Study of BAY3498264 Given Together With Sotorasib in Participants Who Have Advanced Solid Cancers With Specific Genetic Changes Called KRASG12C Mutation [Phase 1]